fbpx
QQQ
-1.93
327.69
-0.59%
DIA
-5.11
352.93
-1.47%
SPY
-4.81
422.91
-1.15%
TLT
-0.76
138.58
-0.55%
GLD
-0.61
172.75
-0.35%

Flowhub, BDS Analytics Partner To Provide Market Insight To Dispensaries

March 26, 2019 12:33 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

The Cannabis Capital Conference is coming back to Toronto! Click here to learn how you can join Tim Seymour, Jon Najarian, Danny Moses, Alan Brochstein and many others.

Flowhub, a provider of cannabis point-of-sale solutions in the U.S., and cannabis data provider BDS Analytics announced a partnership Tuesday in which both companies will integrate their API to provide dispensaries with accurate market insights.

What Happened

Through the integration, which is live as of Tuesday, dispensaries will be able to obtain competitive market data to help them make tactical and strategic decisions, the companies said in a press release. Dispensaries can use the data to better understand their performance and benchmark themselves against the total marketplace. 

Some benefits for dispensaries include the possibility of analyzing market prices; ensuring that products are priced correctly; and making decisions regarding their shelf real estate. The integration could also help dispensaries measure marketing efficacy by tracking ROI on promotional activities and making smart inventory purchasing decisions.

Why It's Important

As the U.S. cannabis market becomes more competitive, a lot of the success of dispensaries relies on their ability to accurately analyze data use it to make decisions. 

Related Links:

The SAFE Banking Act: What Point Of Sale, Compliance Software Providers Think About The Cannabis Banking Bill

Nielsen Enters The Cannabis Industry

Posted-In:

Cannabis News Markets

Related Articles

A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies

As the cannabis industry keeps pushing forward, more companies are moving to list their stock on a major U.S. exchange like the NYSE or NASDAQ. The club, however, remains relatively small. read more

The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More

This was an eventful week for the cannabis industry. read more